|
Cut Cost of Doing Business
| |
Join the SoCalBio Group Purchasing Program to enjoy significant savings on lab supplies and equipment from
Click here to learn more
For more info, call SoCalBio at
800-418-7079 ext 3
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
| Financing | |
The Thousand Oaks-Based Atara Biotherapeutics Announces Second Closing of $52 Million Series B Financing
 Atara Biotherapeutics, Inc., a drug development company with a focus on innovative therapies for patients with debilitating diseases, announced today a second closing of its recently announced Series B financing, bringing the total raised this round to $52 million. Investors in the Series B include Alexandria Venture Investments, Amgen Ventures, The Baupost Group, Celgene Corporation (Nasdaq: CELG), DAG Ventures, Domain Associates, EcoR1 Capital and Kleiner Perkins Caufield & Byers ... Read more
The Irvine-Based Ivantis Rakes in $46.5M and Advances U.S. Trial for Glaucoma Device
 MassDevice reported that the opthalmic devices maker Ivantis padded its Series B funding round with another $14 million raised, bringing the total to $46.5 million. The funds are slated to help Ivantis through 3 large clinical trials and may be enough to get the company through U.S. approval for its Hydrus Microstent glaucoma treatment device ... Read more
|
| Cancer Immunotherapy | |
NeoStem's Subsidiary, Progenitor Cell Therapy (PCT), to Provide Process Development and Manufacturing Services to Kite Pharma
 The West Los Angeles-Based Kite Pharma is developing proprietary cancer immunotherapy products, with a primary focus on eACT designed by Kite to restore the immune system's ability to recognize and eradicate tumors. In connection with Kite's lead eACT clinical development program, anti-CD19 CAR T cells to treat aggressive lymphoma, Kite has engaged PCT for process development services, technology transfer and implementation of the manufacturing process, including manufacturing, packaging, labeling, quality control testing, and product release and storage ... Read more
|
| Inhaled Insulin | |
MannKind Announces Tentative Date of FDA Advisory Committee Review of AFREZZA
 The Valencia-based MannKind Corporation announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is tentatively scheduled on April 1, 2014 to review MannKind's New Drug Application (NDA) for AFREZZA(R) (insulin human [rDNA origin]) Inhalation Powder ... MannKind resubmitted the NDA on October 13, 2013 seeking approval to market AFREZZA in the United States with an indication to improve glycemic control in adults with type 1 or type 2 diabetes. The target date for the FDA to complete its review of the AFREZZA NDA is April 15, 2014 ... Read more
|
| Heart Valves | |
Edwards Lifesciences Feels Competitive Pressure as it Launches a U.S. Trial for Sapien 3 Heart Valve
 Researchers will test Sapien 3 on up to 1,000 intermediate-risk patients with severe symptomatic aortic stenosis, following the FDA's decision to grant an Investigational Device Exemption for a single-arm nonrandomized clinical trial. The latest study follows the completion of an earlier U.S. trial focused on patients with the same condition deemed inoperable or at high risk for surgery ... Read more at Fierce Medical Devices
|
| Emerging Markets | |
The Irvine-Based Masimo Eyes the Indian Market for Expansion
 The Orange County Register reports that Masimo plans a wide expansion of its medical equipment sales efforts in India. The company, which develops devices for noninvasive medical procedures and monitoring, is preparing to meet the demands of what it sees as a huge future market. ... Read more |
|
Moving On
| |
Amgen CFO to Leave Thousand Oaks-Based Biotech Giant
 The LA Times reported that Amgen's chief financial officer, Jonathan M. Peacock, would leave the Thousand Oaks-based biotech company to pursue "broader career opportunities." Amgen has appointed Michael A. Kelly as acting CFO ... Read more
|
| Jobs ... Jobs ... jobs |
Xencor (Monrovia)
Aubery Group (Irvine)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
| Join SoCalBio | |
|
|
|
